Citation: | ZOU Ying, HOU Yan, CHEN Taichun, LI Nijina, ZHANG Dan, ZHANG Hao. Visual analysis of research hotspots and trends of Danggui Shaoyao San from 2000 to 2023[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 34-39. DOI: 10.7619/jcmp.20240880 |
To explore the research status and trends of Danggui Shaoyao San-related literature from 2000 to 2023.
Danggui Shaoyao San-related research literature were searched in four databases: China National Knowledge Internet (CNKI), VIP Chinese Science and Technology Periodical Database (VIP), Wanfang Database, and SinoMed, with the time period set from January 1, 2000 to December 20, 2023. Duplicate literature was removed using the literature management software NoteExpress, and CiteSpace 6.1. R6 was employed to conduct a visual analysis of the literature.
A total of 1, 163 articles were included, and the number of publications showed a fluctuating growth trend from 2000 to 2023. The journal with the highest number of publications was Chinese Journal of Experimental Traditional Medical Formulae (39 articles), the most prolific author was Xu Fan (19 articles), and the institution with the most publications was Henan University of Chinese Medicine (10 articles) and Jiangxi University of Traditional Chinese Medicine (10 articles). High-frequency keywords included "clinical application" "chronic pelvic inflammatory disease" "traditional Chinese medicine therapy" ect., and cluster analysis generated 11 labels.
Research hotspots of Danggui Shaoyao San encompass clinical application, literature textual research, and mechanisms of action, etc. Exploring its mechanisms and targets through network pharmacology and molecular docking technology represents the research trend.
[1] |
洪建华, 卢文滢, 颜冬梅. 当归芍药散方的临床研究进展[J]. 江西医药, 2023, 58(5): 522-526. doi: 10.3969/j.issn.1006-2238.2023.05.002
|
[2] |
任振杰, 张业, 梁帅, 等. 当归芍药散的临床应用及药理作用研究进展[J]. 世界中医药, 2023, 18(23): 3465-3472, 3477.
|
[3] |
陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能[J]. 科学学研究, 2015, 33(2): 242-253. doi: 10.3969/j.issn.1003-2053.2015.02.009
|
[4] |
杨继红, 姚帅君, 陈燕清, 等. 2002—2022年生化汤研究文献可视化分析[J]. 中国中医药信息杂志, 2023, 30(10): 75-80.
|
[5] |
夏青青, 陈偶英, 曾勇, 等. 吴茱萸汤研究热点及趋势可视化分析[J]. 中国中医药信息杂志, 2024, 31(2): 84-89.
|
[6] |
李曼曼, 许钒, 付士平, 等. 基于AngⅡ/TRPC6通路探讨当归芍药散对肾病综合征大鼠足细胞的保护机制[J]. 中国实验方剂学杂志, 2021, 27(19): 9-18.
|
[7] |
范胜楠, 欧美凤, 王运来, 等. 当归芍药散加味黄芪对阿霉素诱导的肾病综合征大鼠的治疗作用[J]. 海南医学院学报, 2021, 27(9): 661-666.
|
[8] |
王鹏, 余伯阳, 林志宏, 等. 当归芍药散精简方对小鼠学习记忆障碍改善作用的物质基础与作用机理研究[J]. 中国实验方剂学杂志, 2004, 10(2): 18-21. doi: 10.3969/j.issn.1005-9903.2004.02.009
|
[9] |
刘洁, 林志宏, 朱丹妮, 等. 当归芍药散防治老年期痴呆的物质基础与作用机理研究Ⅹ: 精简方及其CO2超临界萃取物对星形胶质细胞缺氧损伤的保护作用[J]. 中国实验方剂学杂志, 2007, 13(8): 14-17. doi: 10.3969/j.issn.1005-9903.2007.08.006
|
[10] |
宋祯彦, 何攀, 李富周, 等. 高效液相色谱串联质谱法测定当归芍药散提取物和含药血清中3种活性成分含量[J]. 中国中医药信息杂志, 2021, 28(1): 92-99.
|
[11] |
贺春香, 余婧萍, 李富周, 等. 当归芍药散含药血清对Aβ1-42诱导的SH-SY5Y细胞周期和凋亡的影响[J]. 中成药, 2020, 42(11): 2875-2882. doi: 10.3969/j.issn.1001-1528.2020.11.010
|
[12] |
尹芳, 宋祯彦, 李富周, 等. 基于网络药理学研究当归芍药散防治阿尔茨海默病的作用机制[J]. 药物评价研究, 2018, 41(2): 210-215.
|
[13] |
廉坤, 郭瑾, 李欣春, 等. 2000—2022年慢性心力衰竭血瘀证研究文献可视化分析[J]. 中国中医药信息杂志, 2023, 30(7): 45-50.
|
[14] |
邹颖, 张慧琳, 张庆, 等. 基于CiteSpace的当归四逆汤可视化分析[J]. 湖南中医杂志, 2023, 39(12): 101-106.
|
[15] |
万东平, 张增瑞, 董琪, 等. 基于VOSviewer和CiteSpace的近40年中医药干预强直性脊柱炎知识图谱分析[J]. 中医药导报, 2022, 28(9): 120-126, 132.
|
[16] |
赵立昌, 计忠宁, 夏晶晶. 当归芍药散临床应用及实验研究[J]. 河南中医, 2021, 41(5): 653-655.
|
[17] |
关开, 王晓男. 当归芍药散治疗慢性盆腔炎的临床疗效观察[J]. 中医药信息, 2017, 34(2): 93-95.
|
[18] |
张翠云. 中西医结合治疗单纯性卵巢囊肿疗效观察[J]. 实用中医药杂志, 2017, 33(7): 816-817.
|
[19] |
张琦, 洪恩四, 洪静, 等. 针刺结合当归芍药散治疗气滞血瘀型原发性痛经90例疗效观察[J]. 中国处方药, 2020, 18(5): 115-117.
|
[20] |
汪丽. 真武汤合当归芍药散治疗阳虚血瘀型慢性肾性水肿患者的临床效果观察[J]. 临床合理用药杂志, 2017, 10(29): 7-8.
|
[21] |
李小青, 张亚玲, 朱燃培, 等. 经方当归芍药散的历史沿革及现代临床应用概况[J]. 中国中医基础医学杂志, 2023, 29(11): 1942-1947.
|
[22] |
郭珮, 崔璀, 敬娟, 等. 《金匮要略》妇人病常用方剂药对配伍[J]. 河南中医, 2016, 36(10): 1683-1685.
|
[23] |
肖遥, 李云君. 基于网络药理学探讨当归芍药散治疗复发性流产的作用机制[J]. 湖南中医杂志, 2020, 36(9): 158-164.
|
[24] |
李旦, 吴国庆. 基于网络药理学探讨当归芍药散治疗糖尿病肾病的作用机制[J]. 实用中医内科杂志, 2023, 37(1): 4-7, 144-146.
|
[25] |
毛金花, 耿楠, 路遥, 等. 当归芍药散"异病同治" 慢性盆腔炎和多囊卵巢综合征的网络药理学及分子对接研究[J]. 中国医院用药评价与分析, 2023, 23(3): 257-263, 267.
|
[26] |
许菊香, 陈小桂, 徐胜. 柴胡桂枝干姜汤合当归芍药散联合西药治疗慢性乙型肝炎临床研究[J]. 新中医, 2020, 52(8): 30-33.
|